NF, C., MJ, T., DT, N., TL, L., YH, W., & CY, C. (2021). Immunoassay-Amplified Responses Using a Functionalized MoS2-Based SPR Biosensor to Detect PAPP-A2 in Maternal Serum Samples to Screen for Fetal Down’s Syndrome. Dove Medical Press.
Cita Chicago Style (17a ed.)NF, Chiu, Tai MJ, Nurrohman DT, Lin TL, Wang YH, y Chen CY. Immunoassay-Amplified Responses Using a Functionalized MoS2-Based SPR Biosensor to Detect PAPP-A2 in Maternal Serum Samples to Screen for Fetal Down’s Syndrome. Dove Medical Press, 2021.
Cita MLA (8a ed.)NF, Chiu, et al. Immunoassay-Amplified Responses Using a Functionalized MoS2-Based SPR Biosensor to Detect PAPP-A2 in Maternal Serum Samples to Screen for Fetal Down’s Syndrome. Dove Medical Press, 2021.
Precaución: Estas citas no son 100% exactas.